tiprankstipranks
Pear Therapeutics (PEAR)
NASDAQ:PEAR
US Market

Pear Therapeutics (PEAR) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Strong Sell
5Bullish
1Neutral
16Bearish
Technical Analysis Consensus
Neutral
5Bullish
1Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Pear Therapeutics’s (PEAR) Moving Averages Convergence Divergence (MACD) indicator is -0.15, suggesting Pear Therapeutics is a Sell.
Pear Therapeutics’s (PEAR) 20-Day exponential moving average is 0.19, while Pear Therapeutics’s (PEAR) share price is <$0.1, making it a Sell.
Pear Therapeutics’s (PEAR) 50-Day exponential moving average is 0.51, while Pear Therapeutics’s (PEAR) share price is <$0.1, making it a Sell.

Pear Therapeutics (PEAR) Pivot Points

Apr 18, 2024, 12:44 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
<0.01
0.01
0.02
0.02
0.03
0.03
0.04
Fibonacci
0.01
0.01
0.02
0.02
0.03
0.03
0.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pear Therapeutics (PEAR) Moving Averages

Apr 18, 2024, 12:44 AM
Period
Simple
Exponential
MA5
0.04Sell
0.04Sell
MA10
0.09Sell
0.09Sell
MA20
0.17Sell
0.19Sell
MA50
0.57Sell
0.51Sell
MA100
0.99Sell
0.93Sell
MA200
1.48Sell
1.55Sell
Pear Therapeutics’s (PEAR) 10-Day exponential moving average is 0.09, while Pear Therapeutics’s (PEAR) share price is <$0.1, making it a Sell.
Pear Therapeutics’s (PEAR) 100-Day exponential moving average is 0.93, while Pear Therapeutics’s (PEAR) share price is <$0.1, making it a Sell.
Pear Therapeutics’s (PEAR) stock price is <$0.1 and Pear Therapeutics’s (PEAR) 50-day simple moving average is 0.57, creating a Sell signal.
Pear Therapeutics’s (PEAR) stock price is <$0.1 and Pear Therapeutics’s (PEAR) 100-day simple moving average is 0.99, creating a Sell signal.
Pear Therapeutics’s (PEAR) stock price is <$0.1 and Pear Therapeutics’s (PEAR) 200-day simple moving average is 1.48, creating a Sell signal.

Pear Therapeutics (PEAR) Technical Indicators

Apr 18, 2024, 12:44 AM
Name
Value
Implied Action
RSI (14)
20.89
Buy
STOCH (9,6)
1.64
Buy
STOCHRSI (14)
1.23
Buy
MACD (12,26)
-0.15
Sell
ADX (14)
46.79
Neutral
Williams %R
-98.54
Buy
CCI (14)
-117.13
Buy
ATR (14)
0.06
-
Ultimate Oscillator
23.03
Sell
ROC
-92.31
Sell
Pear Therapeutics’s (PEAR) Relative Strength Index (RSI) is 20.89, creating a Buy signal.
Pear Therapeutics’s (PEAR) Trend Strength Indicator (ADX) is 46.79, creating a Neutral signal.
Pear Therapeutics’s (PEAR) Commodity Channel Index (CCI) is -117.13, creating a Buy signal.
Pear Therapeutics’s (PEAR) Price Rate of Change (ROC) is -92.31, creating a Sell signal.

FAQ

Is PEAR a Buy, Hold, or Sell?
Based on PEAR’s technical indicators, PEAR is a Strong Sell.
    What is PEAR’s RSI (14)?
    PEAR’s RSI (14) is 20.89, which suggests PEAR is a Buy.
      What is PEAR’s MACD?
      PEAR’s MACD is -0.15, which suggests PEAR is a Sell.
        What is PEAR’s 5-day moving average?
        PEAR’s 5-day moving average is 0.04, which suggests PEAR is a Sell.
          What is PEAR’s 20-day moving average?
          PEAR 20-day moving average is 0.17, which suggests PEAR is a Sell.
            What is PEAR’s 50-day moving average?
            PEAR’s 50-day moving average is 0.57, which suggests PEAR is a Sell.
              What is PEAR’s 200-day moving average?
              PEAR’s 200-day moving average is 1.48, which suggests PEAR is a Sell.
                What is PEAR’s Williams % R (14)?
                PEAR’s Williams % R (14) is -98.54, which suggests PEAR is a Buy.
                  What is PEAR’s CCI (14)?
                  PEAR’s CCI (14) is -117.13, which suggests PEAR is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis